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1  |  INTRODUC TION
Aquaculture is the most rapidly growing animal production sector 
and shrimp production already exceeds the capture fishery yield 
(Flegel, 2019). However, intensive shrimp production is facing many 
global challenges, particularly with respect to infectious diseases 
such as Acute Hepatopancreatic Necrosis Disease (AHPND) and 
White Spot Disease (WSD). This scenario has led to the assessment 
that future sustainable shrimp aquaculture will depend on the devel-
opment of more efficient bio- secure production systems that rear 
specific pathogen- free shrimp. This along with genetically improved 
stock for growth and disease tolerance or resistance will be an in-
creasing trend (Castillo- Juárez et al., 2015).
It is also becoming recognized that nutrition and animal health 
are intrinsically related and are now playing a major part in animal 
production including aquatic species such as fish and shrimp with 
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Abstract
Several eco- friendly natural substances can enhance the shrimp immune defence sys-
tem therby acting as a prophylactic agent in feed additives. Agents such as (1, 3)- (1, 6)- D 
β- glucan and complex mannan- oligosaccharides located in yeast cell walls present such 
immunomodulatory and potential prebiotic properties. The aim of our study was to 
evaluate the effect of a commercial yeast cell wall extract (YCW) on shrimp performance 
and health status, and influence on gut microbiota. Juvenile Penaeus vannamei (Boone, 
1931) were raised at an intensive shrimp farm and fed with two different diet inclusions 
levels of YCW, that is, 0.5% and 1.0%, in addition to a yeast free control group. After 
102 days, animals were sampled, and standard nutrition performance parameters were 
measured. Additionally, the phylogenetic profile and composition of shrimp gut micro-
biota were evaluated. Animal performance, including growth and survival, was signifi-
cantly better on animals fed with YCW than the control group. Furthermore, beneficial 
bacteria phylotypes were stimulated by the presence of YCW, positively modulating 
the gut microbiota, with emphasis on 1.0% YCW treatment. Therefore, YCW can be re-
garded as a prophylactic functional agent in the intensive rearing of juvenile P. vannamei 
thus improving animal performance and contributing to a healthy intestinal microbiota.
K E Y W O R D S
feed additive, gut microbiota modulation, nutrition, shrimp growth, shrimp health, Yeast 
extract
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major studies directed to this field (Davies et al., 2019). An optimal 
nutritional condition leads to a satisfactory immune response when 
animals face an infectious or non- infectious challenge such as stress 
and environmental pressures. Nowadays, aiming at an eco- friendly 
and sustainable shrimp farming industry, researchers and farm-
ers are searching for new prophylactic treatments to prevent and 
protect animals against pathogens and increase resistance during 
stressful situations (e.g. disease conditions, environmental distur-
bances, inadequate nutrition, handling) (Thitamadee et al., 2016). 
The concept is to develop nutritional strategies to enhance animal 
health and production, without the use of pharmaceuticals and an-
tibiotics, the latter being of particular concern due to antimicrobial 
resistance and other emerging pathogens.
Natural compounds (nutritional or non- nutritional) can posi-
tively modulate the animal immune system, resulting in increased 
resistance against diseases and/or pathogens (Zhang & Mai, 2014). 
Also, they promote better growth and production efficiency. Many 
of the natural compounds are termed as prebiotics and consist of 
defined carbohydrate cell wall structures mostly originating from 
fungi, bacteria, plants, microalgae and macroalgae (Ringø et al., 
2010; Song et al., 2014). These have proved to be most attrac-
tive for aquaculture as they are derived from natural sources and 
meet consumer expectations for safety and environmental con-
cerns. The yeast cell wall, for example, is composed by different 
polysaccharides (Ringø et al., 2010), which may have prebiotic 
effects. Polysaccharides are polymers of simple sugars with two 
main biological functions: energy storage and extracellular struc-
tural integrity (Nelson & Cox, 2004). The mechanism of action of 
polysaccharides is related to specific binding proteins, opsonins 
and other defence proteins that activate the cellular function when 
reacting with β- glucans or LPS, that is, when the β- glucans bind to 
the receptors on the haemocytes the stimulation of the immune 
response may be initiated (Karunasagar et al., 2014; Meena et al., 
2013; Smith et al., 2014).
The gut microbiota has been described as the ‘new organ’ in 
the animal imparting major systemic effects (Baquero & Nombela, 
2012; McFall- Ngai et al., 2013), with an important role in digestion 
(physiology), nutritional metabolism and influencing immune com-
ponents in disease and inflammatory responses (Akhter et al., 2015). 
The factors to be considered in conducting microbiome research 
were described comprehensively by Goodrich et al., (2014) in terms 
of design, execution and interpretation of data analysis for animal 
studies. To date, less work has been undertaken on fish and shrimp 
compared to other species and humans.
The relevance of the microbiome for the Pacific white shrimp has 
been evaluated by Cornejo- Granados et al., (2017) showing differ-
ential bacterial community composition between wild, aquaculture 
raised and shrimp with AHPND/Early Mortality Syndrome outbreak 
conditions. Wild shrimp presented larger biodiversity gut microbiota 
than shrimp raised under controlled conditions. Likewise, AHPND/
Early Mortality Syndrome led to a loss of hepatopancreas microbi-
ota diversity. These authors have stated that little is known about 
shrimp microbiota remodelling. With all the different scenarios that 
shrimp will encounter, there is a need to relate the microbiota to 
the diet composition and potential to modulate favourably the de-
fence barrier mechanisms in shrimp. There is now much importance 
given to the effect of functional feed additives in aquaculture and 
particularly in fish but also gaining momentum for shrimp (Gainza & 
Romero, 2020). Thus, there is much interest in comprehending the 
links between diet immune stimulants and the microbial ecology of 
the gastrointestinal tract.
It has been stated by Dai et al., (2020) that the gut keystone taxa 
disproportionally affect the function and stability of their resident 
community and thus are candidate targets for improving host health. 
However, exactly how disease progression changes the assembly of gut 
bacterial community remains unclear requiring more elucidation. Their 
influence on shrimp gut microbiota can be a great asset to understand 
patterns in bacteria and environmental changes. Thus, the search to in-
clude sustainable feed supplements into shrimp diets could lead to the 
stabilization of potential beneficial bacteria in the digestive system and 
act as effective control agents to mitigate against disease and infec-
tion. This has been recently comprehensively reviewed by Holt at al. 
(2020). These authors have stated how gut microbiome manipulation 
may offer an attractive option for aquaculture (e.g. improved digestion, 
immunity and health as well as an alternative to antibiotics). It has been 
suggested as a possible alternative to the use of broad- spectrum anti-
biotics in the management of disease processes in shrimp.
Therefore, the purpose of our study was to identify the biologi-
cal potential and environmental and microbial ecological aspects re-
lating to the composition of gut microbiota in cultured shrimp when 
fed with a commercial complex of brewer's yeast cell wall extract 
with supportive proteic by- products (enzymes) from fungus (powder 
from Trichoderma longibrachiatum spp) (PAQ- Gro™ Phibro, Teaneck, 
USA). PAQ- Gro™ is a unique, patented propriety feed additive prod-
uct for fish and shrimp diets. It has been stated that it can improve 
growth performance, FCR, survival rates and the overall health sta-
tus of shrimp and fish during the critical hatchery, nursery and grow- 
out phase. We examine this potential in juvenile Pacific white shrimp 
(Penaeus vannamei Boone, 1931) under typical intensive farming 
conditions employing a commercial propriety feed.
2  |  MATERIAL S AND METHODS
2.1  |  Experimental design
A total of 1,200 juvenile Pacific white shrimp (P. vannamei), 3 g ± 0.25 g, 
were raised for 102 days in an intensive system with seawater with 
minimum water exchange (<10% cycle), in the experimental station of 
Laguna Aquaculture, Colima city, Mexico. Animals were kept in twelve 
floating cages randomly allocated in a 1500 m2 shrimp pond with 
HDPE liner with sand bottom. Floating cages dimensions were as fol-
lows: a) length: 1.60 m; b) width: 1.65 m; depth: 0.60 m; bottom area: 
2.56 m2; volume: 1.58 m3. Floating cages were preferred rather than 
free on the pond due to better control of the trial conditions. A single 
anchoring kept the cages flowing around the ponds. No solid mud or 
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soil was inside the cages, as they were 0.6 m depth. Cages were cov-
ered with 5 mm mess to keep shrimp inside the cages and to avoid 
predation, especially from birds. Shrimp were randomly distributed 
in twelve cages, 100 animals per cage and four cages per treatment. 
Initial shrimp density was 63 shrimp per m3. The same stocking den-
sity was used outside the cages; thus, the standard farm protocol and 
commercial conditions were maintained. Water was pumped from an 
artesian well with oceanic salinity. Constant aeration was provided by 
two horsepower (hp) paddlewheel aerators located outside the float-
ing cages, with total capacity of 16 hp per hectare.
The water quality parameters were monitored daily throughout 
the duration of the trial. The minimum and maximum values ob-
served during the study period were as follows: salinity (33– 35 g L−1), 
ammonia (0.1– 0.3 mg L−1), nitrite (0.2– 0.5 mg L−1), pH (8.5– 9.6), water 
temperature (29– 34°C) and dissolved oxygen (4– 10 mg L−1). Biomass 
measurements occurred weekly, with 20 shrimp per cage, that is, 
20% of the total population were randomly selected with the use of 
nets and individually weighed at the site.
Growth performance and feed efficiency were determined with 
the indexes described below. Statistical analyses were calculated 
using one- way ANOVA, followed by Tukey post hoc test, with a p- 
value < .05 considered statistically significant.
• Survival (%) = [(initial number of shrimp in the cage - final number 
of shrimp in the cage) / initial number of shrimp in the cage] × 100
• Weight gain (g) = final body weight – initial body weight
• Specific growth rate (SGR, g.week−1) = [(ln final shrimp weight – ln 
initial shrimp weight) / days of feeding trial)] x 100
• Feed conversion ratio (FCR) = weight of total feed provided / 
weight gain
• Final yield (g.cage−1) = final net biomass – initial net biomass
2.2  |  Experimental diets
Two different doses of a commercial shrimp feed additive, contain-
ing primarily yeast cell wall components, that is, β- glucans and man-
nans from Saccharomyces cerevisiae (YCW, i.e., PAQ- GroTM Phibro, 
Teaneck, USA), were added ‘on top’ of the shrimp feed formula mix-
ture, and compared to a control group (without YCW supplement). 
Four cages were fed with 5 kg of YCW per tonnes of feed (0.5%), four 
cages were fed with 10 kg of YCW per tonnes of feed (1.0%), while the 
remaining four cages were fed with commercial diet without supple-
ment (control group). A typical shrimp commercial diet, with standard 
commercial nutrient levels, was used as basal diet (Table 1). The proxi-
mate composition of each protein ingredient is presented in Table S1.
Feed was formulated by Azteca Nutrimentos Acuícolas, 
(Tlaquepaque, Guadalajara, Mexico), isonitrogenous (30%) and iso-
energetic (7%), and were prepared using a 250- hp California Pellet 
Mill (Crawfordsville, USA) batches of five tonnes at 2 mm size pellet. 
In Mexico, the current use of wheat flour in shrimp feed ranges from 
30% to 50%. Particularly due to established milling techniques (e.g. 
double preconditioner plus conditioner), it is possible to use a die of 
1.5 mm and achieve a good pellet stabilization. Similarly, kelp hydro-
lysate was used as a binder as it helps in the stabilization of the feed 
pellet with the presence of alginates. Also, the starch from wheat 
flour gelatinization supports the feed stabilization for a minimum of 
two hours under the water. The YCW supplement was added ‘on 
top’ of the commercial formula mixture. It was included with micro 
ingredients in the mash, prepared by mixing the feed in a mixer with 
the YCW prior to standard pelleting. As we have used a standard 
shrimp commercial diet rather than an experimental diet, the tested 
additive was included in addition to the feed blend. It is frequent 
practice under realistic commercial feed mill conditions for testing a 
new product without altering the primary specification.
TA B L E  1  Feed formulation, ingredient profile and nutrient 
analysis of the experimental diets for the trial with Penaeus 
vannamei supplemented with 0.5 and 1.0% (PAQ- Gro™ Phibro, 
Teaneck, USA)
Ingredients (g kg−1) Control 0.5% 1.0%
Fish meala  100 100 100
Soybean mealb  220 220 220
Poultry mealc  180 180 180




Lecithinf  10 10 10
Fish oilg  30 30 30
Soybean oilh  10 10 10
Vitamin premix bi  10 10 10
Mineral premix cj  10 10 10
Vitamin Cl 3 3 3
Antifungalm 1 1 1
Yeast cell wall 
(PAQ- Gro™)
0 5 10
Analysis (g 100 g−1; as fed basis)
Moisture (%) 6 6 6
Crude protein (%) 35 35 35
Crude lipid (%) 8 8 8
Ash (%) 15 15 15
Vitamin PREMIX: Folic Acid 5000 mg kg−1, Biotin 500 mg kg−1, 
Magnesium 150 mg kg−1, Riboflavin 200 mg kg−1, Vitamin D: 1.500 mg 
kg−1, Vitamin E: 90 mg kg−1, Vitamin C: 1000 mg kg−1. Mineral PREMIX: 
Total Calcium 1.846%, Zinc 50 g kg−1, Selenium 200 g kg−1.
aFish Meal, Sonora, Mexico, 
bSoybean meal, Arkansas, USA, 
cPoultry meal, Arkansas, USA 
dWheat Flour, Sonora Mexico, 
eKelp hydrolysates, BCN, Mexico 
fLecithin, Jalisco, Mexico 
gSardine Fish Oil: Guaymas, Mexico 
hSoy oil: Arkansas, USA 
iVitamin Premix: Jalisco Mexico, 
jVitamin C: Jalisco, Mexico 
kAntifungal, USA 
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Feeding rate was adjusted with the use of feeding trays and 
based on the farm's feeding chart recommendations for body per-
centage weight, occurring twice a day. Feed quantity was adjusted 
according to the biomass in the cages, water temperature, and dis-
solved oxygen, and supported by a daily monitoring to check if feed 
remained on trays.
2.3  |  Sample collection
After the 102 days of the feeding trial, the cages were harvested. 
A total of 21 shrimp were randomly sampled for intestine collec-
tion, that is, 7 shrimp per treatment (2 shrimp from the first three 
replicas and 1 shrimp from the fourth replica). Shrimp were eutha-
nized by thermal shock (33– 9°C), carcass surfaces were cleaned with 
70% (v/v) ethanol and the midgut with its content was collected, 
using sterilized forceps and scissors. As shrimp were constantly 
fed, with continuous feeding activity, at the moment of gut collec-
tion, the midgut was filled with the provided feed without natural 
food. Samples were immediately fixed in 70% (v/v) molecular grade 
ethanol, stored in sterile 2 ml microtube, and kept under −20°C for 
subsequent analysis. Transportation for the microbiology laboratory 
at University of Plymouth, UK occurred under the UK Home Office 
importation Licence #TARP/2015/2019.
2.4  |  DNA extraction and 16S rRNA gene 
amplification
DNA extraction was performed with the 21 shrimp gut samples (n = 7 
per treatment) (10 mg ±1.5 mg), using the QIAamp Stool Mini Kit 
(Qiagen®, Hilden, Germany), and following manufacturer's instruc-
tions. In order to enhance the lysis of Gram- positive bacteria, an initial 
incubation with 50 mg mL−1 of lysozyme for 30 min at 37°C was added 
to the protocol. Extracted DNA purity and quantity were measured 
using a UV spectrophotometer (NanoDrop™ 2000 Spectrophotometer, 
ThermoFischer Scientific®, Waltham, USA), based on the ratio of ab-
sorbance at 260/280 nm and 260/230 nm.
A fragment of 350 bp from the hypervariable V1- V2 regions, 
from bacterial 16S ribosomal RNA (16S rRNA gene), was ampli-
fied through a touchdown- polymerase chain reaction (PCR) assay, 
using the primers 27F (5’ AGA GTT TGA TCM TGG CTC AG 3’) 
and a pool of primers 338R- I (5’GCW GCC TCC CGT AGG AGT 
3’) and 338R- II (5’ GCW GCC ACC CGT AGG TCT 3’) (Gajardo 
et al., 2016). For the touchdown- PCR, 1 µl of the DNA template 
(1 ng µl−1) was added to the PCR mix solution containing 25 µl 
of MyTaq™ Red Mix (Bioline®), 1 µl of each primer (25 pM) and 
ultrapure DNase- free water for a final volume of 50 µl. The am-
plification cycling profile is presented in Table 2. To demonstrate 
an accurate PCR performance, positive (Escherichia coli DNA) and 
negative (ultrapure water) controls were used in each amplifica-
tion reaction. Subsequently, the amplified products were analysed 
by 1.5% agarose gel electrophoresis, with SYBR Safe DNA gel 
stain (ThermoFischer Scientific®, Waltham, USA), in TAE buffer at 
constant voltage (80 V) for ~40 min and visualized under UV light 
(300 nm transillumination).
PCR products were purified using AMPure XP (Beckman 
Coulter®), based on the magnetic bead's technology. Finally, purified 
PCR products were sent to Systems Biology Centre of University 
of Plymouth, UK, Genomics Facilities, for the High Throughput 
Sequencing, utilizing Life Technologies Ion Torrent™ Personal 
Genome Machine™ System (ThermoScientific®). All other described 
molecular biology techniques were performed at the Microbiology 
laboratory at the University of Plymouth, UK.
2.5  |  Analysis of high throughput 
sequencing results
The main focus of our study was to address the modulation of the 
gut microbiota with regards to the stabilization of a desirable, sym-
biotic microbiota profile. We adopted the protocols for conducting 
a microbiome study by Goodrich et al., (2014) in terms of design, 
execution and data analysis of the gut microbiome in P. vannamei fed 
the respective treatments.
Raw sequence data were trimmed using FASTX- Toolkit (http://
hanno nlab.cshl.edu/fastx_toolk it/), and sequences with low- quality 
scores (Q < 20) were filtered out. Data were then assessed using 
Quantitative Insights Into Microbial Ecology (Qiime 1.8.0) (Gajardo et al., 
2016). Sequences were analysed using QIIME 1.8.0, and Operational 
Taxonomic Units (OTUs) were sorted and filtered with 97% of sequence 
identity. Ribosomal Database Project tool was used to assign taxonomic 
affiliation, with 0.8 of confidence. Alpha and beta diversity were calcu-
lated with ape, vegan and R. Bacterial richness and diversity were deter-
mined with indexes such as Chao1, Observed Species and Phylogenetic 
diversity. Good's coverage was also identified. Additionally, Weighted 
and Unweighted UniFrac distances were used to estimate similarity and 
dissimilarity and confirmed with Principal Coordinates Analysis (PCoA). 
The taxonomic analysis was estimated with relative abundance graphs 
at phylum and genus level. LEfSe (Linear discriminant analysis effect size) 
tool was used to determine differentially abundant taxa between treat-
ments, and significantly different taxa were used to calculate LDA (linear 




Initial denaturation 94° 7'
Denaturation 94° 30" 10× touchdown
Hybridization 63°– 53° 30"
Elongation 72° 30"
Denaturation 94° 30" 25×
Hybridization 53° 30"
Elongation 72° 30"
Final Elongation 72° 10'
Finalization 10° Until end
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discriminant analysis) effect size (Segata et al., 2012), with a significant 
p- value < .05 and effect size threshold of 2. Finally, the Venn diagram 
was built to identify the core microbiota, as well as unique and shared 
OTUs between treatments, using Venny 2.1 software (http://bioin fogp.
cnb.csic.es/tools/ venny/, Oliveros, 2007- 2015). Data are presented as 
mean ±SD. The p- value < .05 was considered statistically significant.
2.6  |  Data availability
The 16S rRNA gene raw sequence data are deposited and pub-
licly available in NCBI Sequence Read Archive database. BioProject 
ID PRJNA634676, SRA Study SRP263439. Biosamples from 
SAMN15004973 to SAMN15004993. (https://www.ncbi.nlm.nih.
gov/Trace s/study/ ?acc=PRJNA 634676).
2.7  |  Ethics statement
The research was monitored and listed under the guidelines of the 
relevant institutional animal care and guidance committee for all 
projects involving animal work. In the UK, crustaceans including de-
capods and shrimp are not included in the United Kingdom Animal 
Scientific Procedures Act of 1986. This investigation on Pacific 
white shrimp was conducted on a remote commercial farm facility in 
Mexico and conformed to the local state regulations and standards 
for the welfare of shrimp, using propriety feeds and met with the full 
compliance of the farm management committee.
3  |  RESULTS
3.1  |  Growth performance and feed efficiency
Growth performance results are summarized in Table 3. Final shrimp 
survival was statistically different between experimental groups. Both 
treatment groups fed with YCW inclusion in diet displayed significantly 
better survival compared to the control diet. The 0.5% and 1.0% of YCW 
groups presented increased survival by 19% and 23%, respectively, in 
comparison to the control group. All experimental groups presented a 
survival rate above the commercial breaking point at the moment of the 
trial, that is, 45% (calculated based on the price of feed and postlarvae). 
Animals that received 1.0% of YCW showed 4.19% higher final average 
weight, 4.59% higher weight gain and 1.60% higher SGR, in comparison 
to non YCW fed shrimp. These parameters were statistically different 
from the control group. Regarding the FCR, animals from both experi-
mental groups, that is, 0.5% and 1.0% of YCW showed better result 
(43.80% and 47.78% lower in comparison to control group, respec-
tively). In both treatments with YCW, that is, 0.5% and 1.0%, the final 
yield was significantly most advantageous in comparison to the control 
group (51.22% and 66.96% higher than control group, respectively). No 
disease was recorded during the whole trial.
3.2  |  High throughput sequencing results
The microbiota profile of P. vannamei intestine was analysed based 
on the sequencing of the 16S rRNA target gene, using Ion Torrent™ 
technology, in two different feed doses of YCW, that is, 0.5% and 
1.0%, and a control group. Sequencing resulted in a total of 1,983,557 
raw sequences. After removing singletons (OTUs observed fewer 
than two times) and Streptophyta phylum (chloroplast diet associ-
ated), 1,238,780 reads were qualified as high quality. Good´s esti-
mator of coverage presented values above 0.992, demonstrating 
that almost the entire bacterial diversity was identified. The rarefac-
tion curves revealed that a satisfactory sequencing coverage was 
achieved, with signs of saturation for all experimental groups (Figure 
S1). Table 4 summarizes the High Throughput Sequencing results.
3.3  |  Relative abundance at phylum and 
genus levels
Among the five most abundant phyla in the taxonomic analysis 
(Figure 1a), the phyla Fusobacteria and Proteobacteria were the most 
prominent. Fusobacteria phylum was the most abundant in the gut 
TA B L E  3  Growth performance and feed efficiency of Penaeus vannamei fed with two feed doses of Yeast Cell Wall (YCW) and control 
group diets
Control 0.5% YCW 1.0% YCW p- value
Survival (%) 46.00 ± 6.21b 65.50 ± 7.54a 69.00 ± 4.39a 0.0043**
IAW (g shrimp−1) 1.79 ± 0.10 1.79 ± 0.10 1.78 ± 0.10 0.6477
FAW (g shrimp−1) 22.89 ± 0.37b 23.41 ± 0.44ab 23.85 ± 0.45a 0.0318*
Weight gain (g) 21.09 ± 0.36 b 21.61 ± 0.43ab 22.06 ± 0.46a 0.0290*
SGR (g.week−1) 2.50 ± 0.01b 2.52 ± 0.01ab 2.54 ± 0.02a 0.0180*
FCR 4.27 ± 0.86a 2.40 ± 1.04b 2.23 ± 1.43b 0.0006***
Final yield
(g.cage−1)
878.50 ± 148.53b 1328.50 ± 159.30a 1466.75 ± 133.15a 0.0008***
Abbreviations: FAW, Final average weight; FCR, Feed Conversion Ratio; IAW, Initial average weight; SGR, Specific Growth Rate.
Different superscript letters indicate significant differences. Data presented as mean ±SD. (ANOVA, Post hoc Tukey test, p < .05).
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of shrimp that received 0.5% of YCW and in those from the control 
group, the latter group being statistically significantly higher than 
1.0% treatment (p = 0.0029). The intestinal microbiota of animals 
that received 1.0% of YCW presented a high relative abundance of 
phyla Proteobacteria and Fusobacteria, being Proteobacteria rela-
tive abundance significantly higher than 0.5% and control groups 
(p = 0.0073). These two bacterial phyla comprised had relative abun-
dances greater than 80% in all the three analysed groups, that is, 
80%, 82% and 89% in 0.5% and 1% treatment, and control group, 
respectively. Finally, the relative abundance of Bacteroidetes was 
statistically lower in 1% treatment than in control group (p = 0.001).
Similarly, among the ten most abundant genera, the three genera 
Cetobacterium, Sphingobium and Bacillus were more representative 
(Figure 1b) and, summed, represent 77%, 63% and 78% of the total 
relative abundance at genus level on 0.5%, 1.0% and control groups, 
respectively. Moreover, main statistical differences were observed 
in the 1.0% treatment. Cetobacterium was the most abundant genus 
of all and in all the treatments (63.62%, 37.46% and 77.31% for 
0.5%, 1.0% and control groups, respectively), and the 1.0% treat-
ment showed a statistically lower relative abundance of this genus 
in comparison to the two other treatments (p = 0.0029). Then, 
Sphingobium was the second most abundant genus in the gut mi-
crobiota of animals from 1.0% treatment, which presented a higher 
relative abundance in comparison to the control group. Sphingobium 
was significantly higher in both treatments with YCW, in comparison 
to the control group (p = 00058) (5.89%, 19.38% and 0.37% for 0.5%, 
Control 0.5% YCW 1.0% YCW p- value
Reads after trimming 451,475 392,770 394,535 - 
OTUs— Phylum level 15 15 16 - 
OTUs— Genus level 194 202 206 - 
Indexes
Chao 1 419.53 ± 20.09 426.36 ± 26.89 452.84 ± 44.29 0.6733
Observed Species 368.67 ± 17.00 375.98 ± 39.04 407.45 ± 50.45 0.6784
Phylogenetic 
diversity
12.24 ± 0.70 12.40 ± 0.75 12.87 ± 1.30 0.4456
Indexes in samples at a dissimilarity level of 3% (ANOVA, Post hoc Tukey test, p < .05).
TA B L E  4  Summary of High Throughput 
Sequencing result, showing the alpha 
diversity indexes of Penaeus vannamei 
intestinal microbiota, fed with two doses 
of Yeast Cell Wall (YCW) and control 
group diets
F I G U R E  1  Relative abundance of gut microbiota composition of Penaeus vannamei receiving two different doses of Yeast Cell Wall (YCW) 
and control group diets, describing the distribution (%) of bacteria, (a) at the phylum level and (b) at the genus level. ANOVA +Tukey test 
(p < 0.05)
(a)
Different superscript letters indicate significant differences. Data presented as mean (n=7). ANOVA, Post-
hoc Tukey test, p<0.05. 
Phylum name Control 0.5% YCW 1.0% YCW p-value 
Actinobacteria 1.74% 4.29% 3.64% 0.540 
Bacteroidetes 3.15% a 2.11% ab 1.31% b 0.001** 
Firmicutes 5.29% 13.25% 11.57% 0.170 
Fusobacteria 77.34% a 63.65% ab 37.48% b 0.002** 
Proteobacteria 11.89% b 16.11% b 45.44% a 0.007** 
Other 0.59% 0.59% 0.56% - 
 
 
†Family. Different superscript letters indicate significant differences. Data presented as mean (n=7). 
ANOVA, Post-hoc Tukey test, p<0.05. 
Genus name Control 0.5% YCW 1.0% YCW p-value 
Actinetobacter 0.37% b 2.79% ab 6.06% a 0.010* 
Aeromonadaceae† 0.64% b 0.75% b 3.86% a 0.027* 
Bacillus 0.43% b 7.74% a 6.37% a 0.025* 
Bacteroidales† 2.30% a 1.25% b 0.23% c <0.001*** 
Cetobacterium 77.31% a 63.62% ab 37.46% b 0.002** 
Devosia 0.01% b 0.32% b 2.24% a 0.010* 
Enterobacteriaceae† 6.27% 1.87% 2.28% 0.297 
Pseudomonas 0.24% b 0.60% b 1.77% a 0.003** 
Shewanella 1.78% a 0.60% ab 0.26% b 0.016* 
Sphingobium 0.37% b 5.89% a 19.38% a 0.005** 
Other 10.36% 14.55% 20.09% - 
(b)
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1.0%, and control groups, respectively). Lastly, Bacillus was signifi-
cantly higher in both treatments with YCW, in comparison to the 
control group (p = 0.0253) (7.74%, 6.37% and 0.43% for 0.5%, 1.0% 
and control groups, respectively).
3.4  |  Similarities and dissimilarities
Concerning the similarities and dissimilarities of the bacterial popula-
tion, the PCoA revealed a spatial separation between the categories, 
mainly between control and 1.0% treatment. Weighted UniFrac dis-
tance (Figure 2a) showed that 1.0% treatment samples clustered all 
together, with one exception, in the opposite direction of all control 
samples, while 0.5% treatment samples were dispersed. Unweighted 
UniFrac distance (Figure 2b) displayed similar results, with spatial 
differentiation between control and 1.0% treatment, and with five 
of seven 0.5% samples clustering close to control.
3.5  |  Linear discriminant analysis Effect Size.
Regarding possible distinct taxa with statistical significance and bio-
logical relevance, the linear discriminant analysis effect size (LEfSe) 
identified 25 distinct taxa in control group, three on 0.5% YCW 
treatment and 22 on 1.0% YCW treatment that could explain dif-
ferences among treatments (Figure 3). The logarithmic LDA score 
revealed the effect size of each factor, with positive scores ranging 
between 2.0 and 5.0. The gut microbiota of 1.0% YCW treatment 
showed the highest LDA score (5.0) with Sphingobium genus, also 
notable on the relative abundance at the genus level. Further, this 
treatment showed the smallest LDA score, though always above 2.0. 
Control group displayed the greatest quantity of distinct taxa, 25 in 
total, all above or close to 3.0 LDA score, highlighting Shewanella and 
Clostridium genera. Finally, 0.5% YCW treatment revealed only three 
distinct taxa, with LDA score between 3.0 and 4.0.
3.6  |  Venn diagram and shared OTUs
In order to define the intersection list of OTUs between treatments, 
as the core gut microbiota of P. vannamei, as well as to determine 
the unique OTUs of each group, a Venn diagram was constructed, at 
the genus level (Figure 4). Supplementary Material 1 lists the OTUs 
presented in Venn diagram sections. The core gut microbiota com-
prised 57.5% of all identified OTUs, including lactic acid bacteria, 
such as Lactobacillus and Lactococcus, and well- established potential 
probiotics, like Bacillus, Shewanella, Pseudomonas and Halomonas. 
Cetobacterium was also observed in all treatments. Notably, the core 
F I G U R E  2  Similarities and 
dissimilarities of gut microbiota 
composition of Penaeus vannamei 
receiving two different doses of Yeast 
Cell Wall (YCW) and control group diets, 
based on (a) Weighted (the first, second 
and third principal component accounting 
for 88% of the sample variation) and (b) 
Unweighted (per cent variation explained 
42%). UniFrac distances
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microbiota can be understood as the persistent microorganisms of 
the intestinal microbial community, that is, the genera cited above 
were permanent and stable, regardless with or without the presence 
of YCW in the shrimp diet.
Conversely, a number of unique OTUs were observed in each 
treatment. The 1% YCW treatment had the highest quantity, ac-
counting for 9.2% of the total OTUs within the treatment. The con-
trol group presented 1.9% unique OTUs and the 0.5% presented 
3.4% unique OTUs. Additionally, when observing the intersection 
(∩) between the 0.5% and 1.0% YCW treatments (0.5% ∩1.0%), two 
genera were distinct due to their potential and well- known probiotic 
effects, respectively Exiguobacterium and Vibrio. Lastly, 31.9% of the 
OTUs were found exclusively on the gut microbiota of shrimp feed 
with YCW, that is, 66 OTUs were influenced and selected by the 
inclusion of YCW ‘on top’ of shrimp feed.
4  |  DISCUSSION
A high priority for contemporary aquaculture is to find efficient and 
safe technologies for prophylaxis and stimulation of the animal im-
mune system with the associated mechanism of the gut mucosal in-
terface and the role of the gut microbiota. This complex relationship 
has been well described by many authors and more recently by Holt 
at al. (2020).
The present study evaluated the influence of a commercial 
yeast cell wall extract (YCW) on the growth performance and feed 
efficiency of Penaeus vannamei. It also analysed the gut microbiota 
composition of P. vannamei raised on an intensive system, simulating 
commercial shrimp farming conditions (e.g. variability in water tem-
perature, large production, and open pond culture) and thus provid-
ing realistic scenario.
All the growth performance and feed utilization parameters an-
alysed (growth rate, feed conversion efficiency and survival) were 
deemed to be adequate for the established standards for shrimp 
farming. Currently, the standard growth parameters in Mexican 
shrimp farm are growth rate 1 g week−1, FCR 1.6 to 2.0, and sur-
vival rates 40% to 65%. Moreover, animals that received YCW in-
clusion, especially those that were fed with 1.0% YCW, presented 
higher overall performance than the control group. Both treatments 
groups fed diets containing YCW displayed significantly better sur-
vival compared to the control diet. Additionally, when analysing the 
growth parameters, that is, the growth rate and the final weight, an-
imals that received 1.0% YCW feed showed improved performance 
than those that received 0.5% YCW or from the control group. It is 
recognized that the dose and the frequency that various prebiotics 
and immunostimulants are administrated can notably influence ani-
mal response (Zhang & Mai, 2014), and a better performance in our 
investigation was observed in animals fed with 1.0% YCW.
It is worth noting that when doing evaluations under commercial 
conditions, ideal results are rare. Moreover, the economic relevance 
should be the main objective. In the trial described in this article, 
the survival rates and animal performance were significantly supe-
rior compared to the control group and the farm inventory record 
F I G U R E  3  Distinct enriched taxa in the gut microbiota of Penaeus vannamei, with two different doses of Yeast Cell Wall (YCW), that is, 
0.5% and 1.0%, and control group, at genus level. (a) LDA score indicating the scale of difference among taxa. (b) Relative abundance of the 
five most abundant bacteria, at genus level, in order to support LefSe results. p < 0.05; LDA threshold of 2
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logs. Commercial aquaculture is a multi- diverse activity where each 
farm looks for profit or cost benefit rather than simply performance, 
adjusting the parameters according to their market, carrying capac-
ity and productivity. Additionally, in regard to shrimp survival and 
compensatory growth, a typical scenario is when the shrimp popula-
tion reduces, shrimp size increases. This is related to carrying capac-
ity. At our site, typical capacity was 600 g m−3. During our feeding 
trial, final biomass in each tank was maintained above the capacity 
(control group 624 g m3; 0.5% YCW 965 g m−3; 1.0% YCW 978 g 
m−3). Our hypothesis in this regard is that the immune robustness, 
due to inclusion of the tested product, aids the shrimp to maintain 
adequate survival in both treatment groups, but not in the control 
group. Additionally, shrimp survivals are widely interpreted from 
the technical point of view, that is, economic standards and health 
management. The farm records survival rates fluctuate from 40 to 
65% (exempting the trial, survivals range from 40% to 70%), which 
is considered to be a good trend. Our goal in this experiment was to 
link the performance results with the inclusion of the functional feed 
additive and the gut microbiota profile. Thus, we aimed at building a 
scientific case based on the hypothesis that beneficial bacterial can 
increase stress tolerance as well nutrition absorption increasing the 
robustness of the shrimp.
Regarding the growth parameters, the superior performance ob-
served for shrimps that received the YCW may have resulted from 
the direct induction of the immune system by the polysaccharide- rich 
feed, that is, the β- glucan from the yeast cell wall along with other 
constituents such as proteoglycans and mannan- oligosaccharides 
(MOS). Particularly, in our study, the natural compounds found 
within the yeast cell wall matrix appeared to maximize the shrimp 
production in terms of weight gain, feed efficiency and survival.
It should be mentioned that Sajeevan et al., (2009) studied var-
ious doses and different feeding intervals of an insoluble glucan 
extracted from marine yeast in the diet of the Indian white prawn 
(Penaeus indicus Edwards, 1837) infected with white spot syndrome 
virus (WSSV). These authors concluded that a specific combination 
of dose +frequency was decisive for a better shrimp survival similar-
ity. Bai et al., (2014) reported that P. vannamei fed with 0.1% of syn-
thetic carboxymethylglucan in the diet showed the best immunity 
and survival in experimental infection of WSSV; authors tested 18 
different diets, including different β- glucan derivatives and degrees 
of substitution. Moreover, shrimp immunity was kept at high levels 
for up one month when carboxymethylglucan was added in animal 
feed. Particularly, the effect of the immunostimulants in shrimp 
tends to be transitory; thus, special attention should be given to 
a regular frequency and the best dose for optimum results (Smith 
et al., 2014).
The main reason for the use of immunostimulants in aquaculture 
is to attain optimal production, through achieving growth stimula-
tion and promoting animal health and survival as reported by other 
authors (Barman et al., 2013; Mohan et al., 2019; Wang et al., 2017). 
In order to estimate the influence of YCW on shrimp farming output, 
we measured the final shrimp yield. Indeed, the addition of YCW 
resulted in improved final yield, demonstrating that the inclusion of 
the yeast cell wall product in P. vannamei diet enhanced this import-
ant production parameter. Certainly, the continuous shrimp feeding 
management with YCW not only showed no negative effects on ani-
mal performance but also improved the growth parameters, particu-
larly animals that received 1.0% of YCW dietary inclusion.
When analysing the inclusion of a new component to aquafeed, 
it is imperative that it does not lead to an intestinal dysbiosis under 
any circumstances. Moreover, if the new compound favours a ben-
eficial bacteria selection, the greater is the advantage for healthy 
shrimp farming. Based on our results, it is possible to affirm that the 
dietary YCW inclusion for juvenile P. vannamei did not lead to any 
adverse intestinal microbiota imbalance. Moreover, the β- glucan- 
rich MOS product derived from the yeast cell wall also contributed 
to the increase of relevant probiotic genera and preserved the core 
microbiota.
The addition of 1.0% YCW was the treatment that had the most 
influence on the shrimp intestinal microbiota composition. This find-
ing was also corroborated with the PCoA results that revealed a dis-
tinct separation and dissimilarity between 1.0% YCW treatment and 
control group fed shrimp. Animals that received this inclusion level of 
the commercial YCW product presented the phylum Proteobacteria 
as the most prevalent constituent. This phylum, in fact, has been 
reported by other studies as the most dominant in shrimp (Li et al., 
2018; Xiong et al., 2017). Meanwhile, the Fusobacteria phylum was 
the most prevalent in the digestive tract among the animals that 
received 0.5% YCW and those from the control group. This phy-
lum has also been described as one of the most ubiquitous phyla 
F I G U R E  4  Venn diagram showing unique and shared OTUs 
(Operational Taxonomic Units) in the gut microbiome of Penaeus 
vannamei, with two different doses of Yeast Cell Wall (YCW), that 
is, 0.5% and 1.0%, and control group diets, at genus level
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in the intestine of the Pacific white shrimp (Souza Valente et al., 
2020). In fact, these two phyla, among others, were described to 
be part of the autochthonous gut microbiota of P. vannamei, since 
larval until adult stage (Zeng et al., 2017). Moreover, these two 
phyla were reported to be upregulated by WSSV infection (Wang 
et al., 2019). Luis- Villaseñor et al., (2013) addressed that the phyla 
Proteobacteria, Fusobacteria, Sphingobacteria and Flavobacteria 
were the most prevalent in the gut of P. vannamei after being fed 
with a Bacillus probiotic mix.
Those findings can also be observed in the most dominant micro-
bial genera. The genus Cetobacterium was the most predominant in 
all treatments, although significantly lower in 1% YCW. This genus, 
and specifically C. somerae species, is related to the production of 
vitamin B12 (cobalamin) in fish (Rodiles et al., 2018; Tsuchiya et al., 
2008). In Chinese crabs, cobalamin is associated with the nonspe-
cific immune responses (Wei et al., 2014). In shrimp, vitamin B12 is 
commonly supplemented as a form of cyanocobalamin, in optimal 
doses of 0.1 – 0.2 mg kg−1 in complete diets (Koshio, 2014). Although 
there is recent research showing the relation between Cetobacterium 
and cobalamin in fish, there is a lack of studies on this bacterium and 
its role in shrimp. As the most prevalent genera in the three analysed 
group of the present study, certainly this genus is worthy of future 
attention.
Similarly, the genus Sphingobium was higher in the 1.0% 
YCW group in comparison to the control group, indeed reaching 
a relevant percentage of relative abundance for that treatment. 
Sphingobium was isolated from fresh and treated water (Corre 
et al., 2019; Sheu et al.,2013) and, as some bacteria from this 
genus may degrade polycyclic aromatic hydrocarbons, they can 
be used for soil bioremediation (Chen et al., 2016). In the LEfSe 
analysis, this genus was enriched and presented the biggest LDA 
score, showing that this genus had great relevance, and could ex-
plain part of differences between this treatment and the other 
groups. It is a relatively new described genus, first proposed by 
Takeuchi et al., (2001) and, at the moment, it is only mentioned to 
be part of some intestinal shrimp microbiota (Hu et al., 2017), but 
its relevance is rarely discussed. The genus counts as the 40 most 
common taxa found in the arthropod gut microbiota, from soil and 
the aquatic environment (Esposti & Romero, 2017). It was isolated 
from the rhizosphere of an aquaponics system (Schmautz et al., 
2017) and associated with an antibiotic resistance (glycopeptide 
resistance gene) in an experimental aquaculture facility (Colombo 
et al., 2016). The role of this genus on the gut microbiota of shrimp 
from the present study remains unclear.
Noteworthy, the inclusion of YCW within the experimental 
shrimp diets, both at 0.5%, and 1.0%, significantly increased the 
relative abundance of the genus Bacillus in the gut microbiota. This 
result is remarkable due to the significant probiotic importance of 
this genus. Bacillus is considered as an autochthonous member of 
crustacean's environment and is among the widely used probiotic 
bacteria for crustaceans (Castex et al., 2014), mainly due to its ca-
pacity to activate both cellular and humoral shrimp immune re-
sponses (Rengpipat et al., 2000) and to naturally produce antibiotic 
compounds (Van Hai & Fotedar, 2009). Thus, the Bacillus stimulation 
by the YCW diet inclusion is a favourable influence towards mainte-
nance of a healthy shrimp gut microbiota.
Complementary, the inclusion of YCW led to almost no OTU 
suppression. In fact, only 1.9% of the identified OTUs were only 
found in the control group, and we may infer that the inclusion 
of the YCW into the shrimp diet did not suppress an expressive 
number of microorganisms. On the contrary, one- third of the 
OTUs were found exclusively within the gut microbiota of ani-
mals that received the YCW, including Exiguobacterium and Vibrio. 
Exiguobacterium has been proposed to be a potential probiotic for 
P. vannamei (Cong et al., 2017) and may increase shrimp survival 
and growth (Sombatjinda et al., 2014). Moreover, this genus has 
potential biotechnological use to industry and agriculture (Kasana 
& Pandey, 2018). Equally, although Vibrio genus also encompasses 
some opportunistic pathogens, others may act as probiotics 
for crustaceans (Castex et al., 2014), such as Vibrio alginolyticus 
(Austin et al., 1995). Furthermore, Vibrio may play a relevant role 
in enhancing shrimp digestion, due to its genes related to di-
gestive enzymes (Gao et al., 2019). Therefore, shrimp aquafeed 
with YCW not only preserved relevant bacteria genera in the gut 
microbiota but also selected for two other beneficial ones (i.e. 
Exiguobacterium and Vibrio).
Lastly, even with changes observed in the gut microbiota com-
position due to the addition of YCW especially on 1.0% treatment 
that showed dissimilarity to the control group, we noticed a sta-
ble core microbiota. A stable and permanent bacterial community 
was preserved, regardless the addition of YCW in the shrimp diets 
tested in this study. The core microbiota, composed by LAB and 
recognizable or promising probiotic strains in this study, is inti-
mately associated with healthy and diseased animals, being par-
amount on the host– bacteria interaction. A healthy shrimp gut 
microbiota is characterized by a high diversity with cooperative 
interactions, while diseased animals tend to have less diversity and 
simple gut microbiota (Yao et al., 2018). Moreover, when elucidat-
ing the core microbiota composition, it is easier to manipulate it 
in order to develop effective strategies to promote animal health 
and growth (Steinberg, 2018). Thus, the preservation of a healthy 
and balanced gut microbiota, as observed in the inclusion of YCW, 
may result in more resilient and stronger shrimp, likely to better 
respond to stressful situations.
In conclusion, the present study has implied that the dietary 
inclusion of a yeast cell wall extract complex (PAQ- Gro™ Phibro, 
Teaneck, USA) resulted in beneficial attributes for shrimp farming. 
Particularly, for juvenile P. vannamei raised on an intensive floating 
cage system. YCW can be supplied to shrimp as a prophylactic agent 
in order to promote animal performance and gut health, especially at 
a 1.0% inclusion level in a formulated diet.
The product we evaluated (PAQ- Gro™ Phibro, Teaneck, USA) 
is not a pure β- glucan but also contains other important constitu-
ents of the yeast cell wall such as MOS and proteoglycans and en-
zymes from fungal sources that could influence the gut health but 
confounding our understanding of the direct causative effect. As a 
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complex bioactive agent, it may maximize shrimp yield farming prof-
itability, likely providing economic advantages to the producer.
Future studies should also be directed to assessing the cost ben-
efit analyses of YCW under various production scenarios and within 
the context of disease challenge studies with specific pathogenic 
agents encountered in the shrimp farming industry (e.g. White Spot 
Disease and Acute Hepatopancreatic Necrosis Disease). These col-
lectively offer much scope for the future of applying such yeast cell 
wall products as feed supplements in formulated diets for shrimp 
to achieve superior health and resilience. Further work should be 
directed towards metagenomic techniques to establish the function-
ality of the various microbial taxa and specific roles of commensal 
bacteria in relation to the shrimp immune competence.
Additionally, it was shown that supplementation of a propriety 
shrimp feed with a functional feed additive under practical farming 
conditions resulted in positive outcomes for production. This inves-
tigation will therefore allow us to better understand their applica-
tions under varying environmental and rearing conditions for more 
effective control and use of prebiotic type additives for attaining 
superior health status. This will be transformational to achieve a 
more sustainable industry and meet with consumer expectations for 
a superior quality end product.
5  |  DATA STOR AGE AND 
DOCUMENTATION
All data that support the findings presented in the manuscript are 
available within the manuscript and supplemental material.
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